Phaos Technology Holdings (Cayman) (POAS) Other Gross PP&E Adjustments (2024 - 2025)

Phaos Technology Holdings (Cayman) posted quarterly Other Gross PP&E Adjustments of -$38905.0 for Q4 2025, down 106.19% on a QoQ basis from $628169.5 in Q2 2025.

Phaos Technology Holdings (Cayman) (POAS) has 2 years of Other Gross PP&E Adjustments data on file, last reported at -$38905.0 in Q4 2025.

  • For the quarter ending Q4 2025, Other Gross PP&E Adjustments changed N/A year-over-year to -$38905.0; the trailing twelve-month figure through Oct 2025 stood at -$38905.0 (changed N/A YoY), and the FY2025 full-year result was $643197.0, up 59.07% from the prior year.
  • Other Gross PP&E Adjustments for Q4 2025 stood at -$38905.0, down from $628169.5 in the prior quarter.
  • Across five years, Other Gross PP&E Adjustments topped out at $628169.5 in Q2 2025 and bottomed at -$38905.0 in Q4 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Gross PP&E Adjustments (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 23.14 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn -
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -405.00 Mn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn -547.00 Mn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -99.30 Mn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 2.55 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 2.39 Bn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 5.30 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 991.00 Mn
10 Phaos Technology Holdings (Cayman) 6.83 Mn 6.73 Mn - -38,905.00

Historic Data

Download Data 🔒
DateValue
Oct 31, 2025 -38,905.00
Oct 31, 2025 -38,905.00
Apr 30, 2025 628,169.51
Apr 30, 2025 628,169.51
Apr 30, 2024 404,345.46
Apr 30, 2024 404,345.46